FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079851043> ?p ?o ?g. }

• W2079851043 endingPage "195" @default.
• W2079851043 startingPage "179" @default.
• W2079851043 abstract "Cyclooxygenase (COX) is a key rate-limiting enzyme for prostaglandin (PG) production cascades in the human body. The mechanisms of both the anti-inflammation effects and the side-effects of traditional COX inhibitors are associated with the existence of two COX isoforms. Thus while COX-1 is predominantly expressed ubiquitously and constitutively, and it serves a housekeeping role in processes such as gastrointestinal (GI) mucosa protection, COX-2 is absent or exhibits a low level of expression in most tissues, and is highly upregulated in response to endotoxin, virus, inflammatory or tissue-injury stimuli/signals, and tumour promoter in the various types of organs, tissues, and cells. Furthermore, COX-2 contribution to PGE(2) and PGI(2) production evokes and sustains systemic or peripheral inflammatory disease, but it is not involved in the COX-1-mediated GI tract events. Also, hypersensitivity of aspirin owing to its inhibitory action against COX-1 is a significant concern clinically. Consequently, highly selective COX-2 inhibitors have been needed for the treatment of inflammatory- and inflammation related-diseases that include pyrexia, inflammation, pain, rheumatoid arthritis, osteoarthritis, and cancers. In this study, a series of novel [2-{[(4-substituted or 4,5-disubstituted)-pyridin-2-yl]carbonyl}-(5- or 6-substituted or 5,6-disubstituted)-1H-indol-3-yl]acetic acid analogues was designed, synthesized, and evaluated to identify potent and selective COX-2 inhibitors as potential agents against inflammatory diseases. As significant findings, the present study clarified unique structure-activity relationship of the analogues toward potent and selective COX-2 inhibition in vitro, and identified 2-{6-fluoro-2-[4-methyl-2-pridinyl)carbonyl]-1H-indol-3-yl}acetic acid as a potent and selective COX-2 inhibitor in vitro that demonstrated orally potent anti-inflammation efficacy against carrageenan-induced oedema formation in the foot of SPF/VAF male SD rats as a peripheral inflammation model in vivo." @default.
• W2079851043 created "2016-06-24" @default.
• W2079851043 creator A5007134478 @default.
• W2079851043 creator A5009415791 @default.
• W2079851043 creator A5028603816 @default.
• W2079851043 creator A5036238907 @default.
• W2079851043 creator A5057820056 @default.
• W2079851043 date "2012-04-01" @default.
• W2079851043 modified "2023-09-27" @default.
• W2079851043 title "Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug" @default.
• W2079851043 cites W1586509612 @default.
• W2079851043 cites W1970652854 @default.
• W2079851043 cites W1971605286 @default.
• W2079851043 cites W1972773419 @default.
• W2079851043 cites W1974450761 @default.
• W2079851043 cites W1974630175 @default.
• W2079851043 cites W1979217561 @default.
• W2079851043 cites W1981081599 @default.
• W2079851043 cites W1981736539 @default.
• W2079851043 cites W1981819970 @default.
• W2079851043 cites W1993881834 @default.
• W2079851043 cites W1994147874 @default.
• W2079851043 cites W1994442506 @default.
• W2079851043 cites W1995657296 @default.
• W2079851043 cites W1998976537 @default.
• W2079851043 cites W2007187686 @default.
• W2079851043 cites W2007999404 @default.
• W2079851043 cites W2010967782 @default.
• W2079851043 cites W2020092959 @default.
• W2079851043 cites W2024608254 @default.
• W2079851043 cites W2036913490 @default.
• W2079851043 cites W2037182281 @default.
• W2079851043 cites W2038410983 @default.
• W2079851043 cites W2047142196 @default.
• W2079851043 cites W2054521231 @default.
• W2079851043 cites W2055521278 @default.
• W2079851043 cites W2059885690 @default.
• W2079851043 cites W2063369648 @default.
• W2079851043 cites W2066074947 @default.
• W2079851043 cites W2066573736 @default.
• W2079851043 cites W2077758644 @default.
• W2079851043 cites W2083810819 @default.
• W2079851043 cites W2083917519 @default.
• W2079851043 cites W2089923844 @default.
• W2079851043 cites W2090051601 @default.
• W2079851043 cites W2093565689 @default.
• W2079851043 cites W2093731034 @default.
• W2079851043 cites W2095950170 @default.
• W2079851043 cites W2097716284 @default.
• W2079851043 cites W2105732889 @default.
• W2079851043 cites W2106607260 @default.
• W2079851043 cites W2113745276 @default.
• W2079851043 cites W2116979908 @default.
• W2079851043 cites W2117558614 @default.
• W2079851043 cites W2119689902 @default.
• W2079851043 cites W2120033129 @default.
• W2079851043 cites W2122520739 @default.
• W2079851043 cites W2130812549 @default.
• W2079851043 cites W2134927810 @default.
• W2079851043 cites W2138256041 @default.
• W2079851043 cites W2151978506 @default.
• W2079851043 cites W2157031970 @default.
• W2079851043 cites W2158238943 @default.
• W2079851043 cites W2158960911 @default.
• W2079851043 cites W2162607473 @default.
• W2079851043 cites W2318926966 @default.
• W2079851043 cites W2395904446 @default.
• W2079851043 cites W2468150319 @default.
• W2079851043 cites W2949732074 @default.
• W2079851043 cites W2969445 @default.
• W2079851043 cites W4255600841 @default.
• W2079851043 doi "https://doi.org/10.1016/j.ejmech.2012.01.053" @default.
• W2079851043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22373734" @default.
• W2079851043 hasPublicationYear "2012" @default.
• W2079851043 type Work @default.
• W2079851043 sameAs 2079851043 @default.
• W2079851043 citedByCount "36" @default.
• W2079851043 countsByYear W20798510432012 @default.
• W2079851043 countsByYear W20798510432013 @default.
• W2079851043 countsByYear W20798510432014 @default.
• W2079851043 countsByYear W20798510432015 @default.
• W2079851043 countsByYear W20798510432016 @default.
• W2079851043 countsByYear W20798510432017 @default.
• W2079851043 countsByYear W20798510432018 @default.
• W2079851043 countsByYear W20798510432019 @default.
• W2079851043 countsByYear W20798510432020 @default.
• W2079851043 countsByYear W20798510432021 @default.
• W2079851043 countsByYear W20798510432022 @default.
• W2079851043 countsByYear W20798510432023 @default.
• W2079851043 crossrefType "journal-article" @default.
• W2079851043 hasAuthorship W2079851043A5007134478 @default.
• W2079851043 hasAuthorship W2079851043A5009415791 @default.
• W2079851043 hasAuthorship W2079851043A5028603816 @default.
• W2079851043 hasAuthorship W2079851043A5036238907 @default.
• W2079851043 hasAuthorship W2079851043A5057820056 @default.
• W2079851043 hasConcept C142724271 @default.
• W2079851043 hasConcept C181199279 @default.
• W2079851043 hasConcept C185592680 @default.

• next